Background Follicular lymphoma (FL) is the most common indolent and second most
common Non‐Hodgkins lymphoma (NHL) in the Western world. Standard treatment usually …

There are two different international standards for the treatment of follicular lymphoma (FL):
intensified therapy followed by autologous stem‐cell transplantation (ASCT) and …

Background The impact of high-dose therapy and autologous stem cell transplantation
(ASCT) vs conventional-dose chemotherapy in the initial management of adults with …

Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma (NHL) in
North America. Because of the heterogeneity of the disease, treatment options vary from …

Published studies have provided conflicting results regarding the curative potential of high
dose chemotherapy and autologous stem cell transplant (HDT/ASCT) for follicular …

BACKGROUND Despite international practice guidelines endorsing radiotherapy (RT) as
the preferred initial therapy, treatment approaches vary for patients with early‐stage follicular …

The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …

Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …

Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

Background The emergence of novel and efficient antibody maintenance approaches has
provided more options for post‐induction treatment of advanced follicular lymphoma (FL) …